µå·¯±×ÀÎÆ÷ ¾àǰ¿ä¾àÁ¤º¸ - À̼öǪ·¼ÁÖ(À̼ÒÇÁ·ÎÅ×·¹³î¿°»ê¿°) 1mL
µå·°ÀÎÆ÷¸¦ ½ÃÀÛÆäÀÌÁö·Î   ·Î±×ÀΠȸ¿ø°¡ÀÔ ³»ÄÁÅÙÃ÷ÇÔ contacts
BIT Druginfo
  ½ÅÅëÇÕ°Ë»ö  
¾àǰ°Ë»ö|ÀÓºÎÅõ¿©|ATCºÐ·ùÄÚµå|ÀûÀÀÁõ|ÇѾà(»ý¾à)»çÁø|¾àÈ¿ºÐ·ù
¾àǰ°Ë»ö Á¦Ç°½Äº° »óÈ£ÀÛ¿ë ¼ººÐÁ¤º¸ ȯÀÚº¹¾àÁöµµ ¾àÁ¦ºñ½É»çÁöħ ÇàÀ§°ü·Ã½É»çÁöħ °Ô½ÃÆÇ Ä¿¹Â´ÏƼ
 
 
top
¾ÆÀ̵ðÀúÀå
line
ȸ¿ø°¡ÀÔ ¾ÆÀ̵ðºñ¹Ð¹øÈ£Ã£±â
·Î±ä¹®Á¦
bottom
¾àǰ°Ë»ö
À̼öǪ·¼ÁÖ
Çٽɿä¾àÁ¤º¸
¿ä¾àÁ¤º¸
»ó¼¼Á¤º¸
´ëü°¡´É/µ¿ÀϼººÐÀǾàǰ
»óÈ£ÀÛ¿ë
°ü·Ã¾àÈ¿ºÐ·ù
½ÉºÎÀüÄ¡·áÁ¦ (Drugs for Heart Failure)
°ü·Ã¾à¹°Ã£±â
ȯÀÚº¹¾àÁöµµ
¿ä¾à º¹¾à ¾È³»¹®
»ó¼¼ º¹¾à ¾È³»¹®
Á¦Çüº° º¹¾àÁöµµ
Á¦Ç°º° º¹¾àÁöµµ
Áúȯº° º¹¾àÁöµµ
Á¾ÇÕ º¹¾à ¾È³»¹®
¾àÁ¦ºñ½É»çÁöħ
Disclaimer
¾Ë·ÁÁø Á¦Ç°º° ¾àÁ¦ºñ
½É»çÁöħÀÌ È®ÀεÇÁö ¾Ê¾Ò½À´Ï´Ù.
ÀϹݿøÄ¢ Á¶È¸¸¦ À§ÇØ Å¬¸¯Çϼ¼¿ä.
½É»ç»ç·Ê
±âŸ °Ë»ö
ATC Äڵ庰
¼ººÐº°
ÀûÀÀÁõº°
º´¿ë±Ý±â ÀǾàǰ
ÀӺαݱâ ÀǾàǰ
ºñ¿ëÈ¿°úÀû ÇÔ·® ÀǾàǰ
ATCÄÚµå °Ë»ö
ÀûÀÀÁõ °Ë»ö
»ý¾à¸í °Ë»ö
Medline °Ë»ö
Isoproterenol HCl
My Drug Picture
My Drug List
¿ÀŸ½Å°í
bottom
Á¦Ç°ÄÚµå(KD)
Ç¥ÁØÄÚµå(¹ÙÄÚµå)
ǰ¸ñ±âÁØÄÚµå
bottom

ÇàÀ§Á¤ÀÇ+½É»çÁöħ
ÇàÀ§ Á¤ÀÇ
ÇàÀ§ ½É»çÁöħ
ÇàÀ§Á¤ÀÇ+½É»çÁöħ
ºÎ°¡Á¤º¸°Ë»ö
󹿻ç·Ê
ÀÌ»ó¹ÝÀÀ ¹× ´ëó¹ý
ÀÓ»êºÎ¸¦ À§ÇÑ
¿µ¾ç°ü¸®
ÀǾàǰ
¾ÈÀü»ç¿ë ¸Þ´º¾ó
KMLE ÀÇÇпë¾î
½º¸¶Æ®Æù
µå·°ÀÎÆ÷ ¸ð¹ÙÀÏ
bottom
 
 
 
   
¾àǰ°Ë»ö ¿ä¾àÁ¤º¸
 
 
À̼öǪ·¼ÁÖ(À̼ÒÇÁ·ÎÅ×·¹³î¿°»ê¿°) 1mL  ISU PREL INJ.  
Àü¹®ÀǾàǰ | »èÁ¦
¼öÀÔÀǾàǰ
 
¾Ë¸²: µå·°ÀÎÆ÷¿¡¼­´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù.
īī¿À½ºÅ丮 Æ®À§ÅÍ ÆäÀ̽ººÏ Á¤º¸°¡ºÎÁ·ÇϽŰ¡¿ä?
Àü¹®/ÀÏ¹Ý Àü¹®
¹«»öÀÇ ¿ë¾×ÀÌ µé¾îÀÖ´Â ¾ÚÇÃ
µ¿ÀϾà½Äº°»çÁø
ȸ¿øÁ¦°ø»çÁø
Á¦Á¶È¸»ç Çѱ¹È­ÀÌÀÚÁ¦¾à(ÁÖ)
ÆÇ¸Åȸ»ç Çѱ¹È­ÀÌÀÚÁ¦¾à(ÁÖ)
Çã°¡Á¤º¸ ÃëÇÏ (2025.01.01)
BIT ¾àÈ¿ºÐ·ù ½ÉºÎÀüÄ¡·áÁ¦ (Drugs for Heart Failure)
º¹ÁöºÎºÐ·ù 222[ÁøÇذŴãÁ¦ ]
û±¸ÄÚµå(KDÄÚµå)
   ºñ±Þ¿©Á¡°ËÄÚµå
648903061
\0 ¿ø/1mL/¾ÚÇÃ(2025.08.01)(ÇöÀç¾à°¡)
\3,736 ¿ø/1mL/¾ÚÇÃ(2017.02.01)(º¯°æÀü¾à°¡)
ATCÄÚµå isoprenaline / C01CA02
NDCÄÚµå [Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
¼ººÐ / ÇÔ·® [½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

1mL Áß
Isoproterenol HCl 0.2mg  Á¦Ç° °Ë»ö
÷°¡Á¦ ¼ö»êÈ­³ªÆ®·ý, ½ÃÆ®¸£»ê, ½ÃÆ®¸£»ê³ªÆ®·ý¼öÈ­¹°, ¿¡µ¥Æ®»ê³ªÆ®·ý, ¿°»ê, ¿°È­³ªÆ®·ý, ÁÖ»ç¿ë¼ö
 
  ¸¶À̵巯±×ÀúÀå ¸¶À̵巯±×µµ¿ò¸»

Çã°¡Á¤º¸ Á¤º¸¿ä¾à ÄÚµå ¹× ºÐ·ùÁ¤º¸ Á¦Ç°Á¤º¸ º¹¾àÁ¤º¸ ½É»çÁ¤º¸ ÇмúÁ¤º¸ »ç¿ëÀÚÄÁÅÙÃ÷ Àüü
À¯·áȸ¿ø °áÀç½Ã¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸¸¦ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù. À¯·áÁ¤º¸¸ñ·ÏÀº Àü¹®È¸¿øÀ¸·Î ·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
iconÇã°¡Á¤º¸
Ç׸ñ ³»¿ë
û±¸ÄÚµå(KDÄÚµå)
ºñ±Þ¿©Á¡°ËÄÚµå
»óÇѱݾ×
648903061   [º¸ÇèÄڵ忡 µû¸¥ ¾àǰ±âº»Á¤º¸ Á÷Á¢Á¶È¸]
\0 ¿ø/1mL/¾ÚÇÃ(2025.08.01)(ÇöÀç¾à°¡)
\3,736 ¿ø/1mL/¾ÚÇÃ(2017.02.01)(º¯°æÀü¾à°¡)
[»óº´ÄÚµåÁ¶È¸]
[Áúº´ÄÚµåÁ¶È¸]
ºü¸¥Á¶È¸
¿ä¾àÁ¤º¸ [È¿´É] [¿ë¹ý] [±Ý±â] [½ÅÁßÅõ¿©] [ÀÌ»ó¹ÝÀÀ]
»ó¼¼Á¤º¸ [È¿´É] [¿ë¹ý] [°æ°í] [±Ý±â] [½ÅÁßÅõ¿©] [ÀÌ»ó¹ÝÀÀ] [ÀϹÝÁÖÀÇ] [»óÈ£ÀÛ¿ë] [ÀÓ»êºÎ] [¼öÀ¯ºÎ] [¼Ò¾Æ] [°í·ÉÀÚ] [½ÅÀå¾ÖȯÀÚ] [°£Àå¾ÖȯÀÚ] [Àû¿ëÁÖÀÇ] [°ú·®Åõ¿©] [ÀÓ»ó°Ë»çÄ¡] [º¸°ü] [±âŸ]
Á¦Ç°¼º»ó ¹«»öÀÇ ¿ë¾×ÀÌ µé¾îÀÖ´Â ¾ÚÇà [Á¦ÇüÁ¤º¸ È®ÀÎ]
Æ÷À塤À¯Åë´ÜÀ§ 0.2mg/mLX25¾ÚÇÃ
Æ÷À塤ÄÚµå´ÜÀ§
¾àǰ±Ô°Ý ´ÜÀ§ Æ÷ÀåÇüÅ ´ëÇ¥ÄÚµå Ç¥ÁØÄÚµå ºñ°í
1¹Ð¸®¸®ÅÍ 25 ¾ÚÇà ¾ÚÇà 8806489030604 8806489030628
1¹Ð¸®¸®ÅÍ 1 ¾ÚÇà ¾ÚÇà 8806489030604 8806489030611
ÁÖ¼ººÐÄÚµå 178330BIJ   [µ¿ÀÏÇÑ ÁÖ¼ººÐÄڵ带 °¡Áø ¿À¸®Áö³¯ ¶Ç´Â Á¦³×¸¯ ÀǾàǰ Á¶È¸]
Çã°¡»çÇ× ¿ø¹®Á¶È¸ [Çã°¡»çÇ× ¿ø¹®Á¶È¸]
È¿´ÉÈ¿°ú [ÀûÀÀÁõ º° °Ë»ö]   

1. Adams-Stokes ÁõÈıºÀÇ ¹ßÀÛ ½Ã(°íµµÀÇ ¼­¸Æ, ½É¹Úµ¿Á¤Áö Æ÷ÇÔ)

2. ½É±Ù°æ»öÀ̳ª ¼¼±Õ ³» µ¶¼Ò µî¿¡ ÀÇÇÑ ±Þ¼º ½ÉºÎÀü, ¼ö¼ú ÈÄÀÇ Àú½É¹ÚÃâ·® ÁõÈıº

[Áúȯº° º¹¾àÁöµµ]
¿ë¹ý¿ë·® * Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù.
   
[󹿾à¾î]

1. Á¡Àû Á¤¸ÆÁÖ»ç

Ãʱâ¿ë·®À¸·Î À̼ÒÇÁ·ÎÅ×·¹³î¿°»ê¿°À¸·Î¼­ 1 ¢¦ 2 mg(5 ¢¦ 10 mL)À» 5 % Æ÷µµ´çÁÖ»ç¾× 500 mL¿¡ Èñ¼®ÇÏ¿© ºÐ´ç 0.5 ¢¦ 5 ¥ìg(Èñ¼®¾× 0.25 ¢¦ 2.5 mL)ÀÇ ¼Óµµ·Î ½É¹Ú¼ö ¶Ç´Â ½ÉÀüµµ¸¦ ¸ð´ÏÅÍÇϸ鼭 Á¡Àû Á¤¸ÆÁÖ»çÇÑ´Ù.

2. Bolus Á¤¸ÆÁÖ»ç

Ãʱâ¿ë·®À¸·Î 0.2 mg(1 mL)À» 5 % Æ÷µµ´çÁÖ»ç¾× ¶Ç´Â »ý¸®½Ä¿°ÁÖ»ç¾× 10 mL¿¡ Èñ¼®ÇÏ¿© õõÈ÷ Á¤¸ÆÁÖ»çÇÑ´Ù.

3. ±ÙÀ° ¶Ç´Â ÇÇÇÏÁÖ»ç

Èñ¼®µÇÁö ¾ÊÀº 1 : 5,000¿ë¾× 0.2 mg(1 mL)À» ±ÙÀ° ¶Ç´Â ÇÇÇÏÁÖ»çÇÑ´Ù.

4. ½ÉÀå³» ÁÖ»ç

Èñ¼®µÇÁö ¾ÊÀº 1 : 5,000¿ë¾× 0.02 mg(0.1 mL)À» ½ÉÀå³» ÁÖ»çÇÑ´Ù.

Áõ»ó¿¡ µû¶ó ÀûÀýÈ÷ Áõ°¨ÇÑ´Ù.

[BMIÁö¼ö °è»ê] [Body Surface Area °è»ê] [Cockcroft-Gault GFR °è»ê] [MDRD GFR °è»ê]
ÁÖ¿ä¾à¹° »óÈ£ÀÛ¿ë [Á¶È¸]
±Ý±â

1) ÀÌ ¾à ¶Ç´Â ÀÌ ¾àÀÇ ±¸¼º¼ººÐ¿¡ °ú¹Î¹ÝÀÀÀÇ º´·ÂÀÌ Àִ ȯÀÚ

2) ÁßÁõ °íÇ÷¾Ð ȯÀÚ

3) ÁßÁõ ½ÅÁúȯ ȯÀÚ

4) °©»ó»ù±â´ÉÇ×ÁøÁõ ȯÀÚ

5) ºó¸Æ¼º ºÎÁ¤¸Æ ¶Ç´Â ±× º´·ÂÀÌ Àִ ȯÀÚ

6) ºñÈļº ½É±Ùº´Áõ ȯÀÚ

7) µð±âÅ»¸®½ºÁßµ¶¿¡ ÀÇÇÑ ºó¸Æ ¶Ç´Â ½ÉÂ÷´Ü ȯÀÚ

8) Çù½ÉÁõ ȯÀÚ

9) ½É½ÇºÎÁ¤¸Æ ȯÀÚ

10) µ¿¼ººó¸Æ(130bpm Ãʰú) ȯÀÚ

11) ½É¹æ ¹× ½É½Ç °úÈïºÐ ȯÀÚ

12) ±Þ¼º °ü»óµ¿¸ÆºÎÀü ȯÀÚ

13) ±Þ¼º ½É±Ù°æ»öÁõ ȯÀÚ

½ÅÁßÅõ¿©

1) ´Ù¸¥ ±³°¨½Å°æÈïºÐ¾à¿¡ °ú¹Î¹ÝÀÀ ȯÀÚ

2) ´Ù¸¥ ±³°¨½Å°æÈïºÐ¾àÀ» Åõ¿© ¹Þ°í Àִ ȯÀÚ

3) ´ç´¢º´ ȯÀÚ

4) °ü»óµ¿¸ÆÁúȯ ȯÀÚ

5) ¿ïÇ÷½ÉºÎÀü ȯÀÚ

6) °íÇ÷¾Ð ȯÀÚ

ÀÌ»ó¹ÝÀÀ

1) Á¤½Å½Å°æ°è : ¹ßÇÑ, ¶§¶§·Î µÎÅë, ¼öÁöÁøÀü, Á¹À½, µå¹°°Ô ¾îÁö·³, ½Å°æ°ú¹Î, ºÒ¸é µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.

2) ¼øÈ¯±â°è : ¾È¸éÈ«Á¶•â¹é, Çù½ÉÁõ, ÆóºÎÁ¾, ÀúÇ÷¾Ð, ºÎÁ¤¸Æ, ºó¸Æ, Adams-Stokes ¹ßÀÛ, ¶§¶§·Î ½É°èÇ×Áø, Ç÷¾Ðº¯µ¿, µå¹°°Ô °íÇ÷¾Ð µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.

3) ¼ÒÈ­±â°è : À§Åë, ¼³»ç, º¹ºÎÆØ¸¸°¨, ¶§¶§·Î ½Ä¿åºÎÁø, ¼ÒÈ­ºÒ·®, ±¸¿ª, ±¸Åä µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.

4) È£Èí±â°è : µå¹°°Ô ±âħ, ±â°üÁö¿°, õ¸í, ¸Å¿ì µå¹°°Ô Àεο°, ºñÃæÇ÷ÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.

5) °ú¹Î¹ÝÀÀ : ¸Å¿ì µå¹°°Ô ÇǺιßÁø, Ç÷°üºÎÁ¾, µÎµå·¯±â, ±â°üÁö°æ·Ã, ±¸°­ÀεκÎÁ¾, °íÇ÷¾Ð, ÇãÅ» µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¹Ç·Î ÀÌ·¯ÇÑ °æ¿ì¿¡´Â Åõ¿©¸¦ ÁßÁöÇÑ´Ù.

6) ±âŸ : µå¹°°Ô ±¸°¥, ±¸³»¿°ÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.

[ÁÖ¿ä ÀÌ»ó¹ÝÀÀÁ¤º¸]
»óÈ£ÀÛ¿ë

1) ¿¡Çdz×ÇÁ¸° µîÀÇ Ä«Å×Äݾƹηù¿Í º´¿ëÇÏ¸é ºÎÁ¤¸Æ ¶Ç´Â ½ÉÁ¤Áö¸¦ ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¹Ç·Î º´¿ëÅõ¿©ÇÏÁö ¾Ê´Â´Ù.

2) MAO¾ïÁ¦Á¦³ª »ïȯ°è Ç׿ì¿ïÁ¦·Î Ä¡·áÁßÀΠȯÀÚ¿¡°Ô ÀÌ ¾àÀ» Åõ¿©Çϸé ÀÌ ¾àÀÇ Ç÷°ü°è¿¡ ´ëÇÑ ÀÛ¿ëÀÌ Áõ°¡µÉ ¼ö ÀÖÀ¸¹Ç·Î ƯÈ÷ ÁÖÀÇÇÑ´Ù.

3) ±³°¨½Å°æÀÛ¿ë ¾Æ¹Î·ùÀÇ ½É±Ù¿¡ °­·ÂÇÑ ¹Î°¨È­ È¿°ú·Î ÀÎÇØ ÇÒ·Îź°ú °°Àº ÈíÀÔ¸¶ÃëÁ¦ »ç¿ë ½Ã ÀÌ ¾àÀ» »ç¿ëÀº ÇÇÇØ¾ß ÇÑ´Ù.

4) ÀÜÆ¾°è ¾à¹°: ¸ÞÆ¿ÀÜÆ¾°è ¾à¹°(¾Æ¹Ì³ëÇʸ°, Å׿ÀÇʸ°)°ú ÀÌ ¾àÀ» º´¿ëÇÏ¿© Áö¼ÓÀûÀ¸·Î Á¤¸Æ³»Åõ¿© ÇÒ ¶§, ¸ÞÆ¿ÀÜÆ¾°è ¾à¹°ÀÇ Ç÷û ³óµµ°¡ °¨¼ÒµÉ ¼ö ÀÖÀ¸¹Ç·Î ÁÖÀÇÇÑ´Ù.

Off-label Usage [Á¶È¸]
Related FDA Approved Drug
±âÁØ ¼ººÐ:ISOPROTERENOL HYDROCHLORIDE
AEROLONE (ISOPROTERENOL HYDROCHLORIDE)
DUO-MEDIHALER (ISOPROTERENOL HYDROCHLORIDE; PHENYLEPHRINE BITARTRATE)
ISOPROTERENOL HYDROCHLORIDE (ISOPROTERENOL HYDROCHLORIDE)
ISUPREL (ISOPROTERENOL HYDROCHLORIDE)
MUCOMYST W/ ISOPROTERENOL (ACETYLCYSTEINE; ISOPROTERENOL HYDROCHLORIDE)
NORISODRINE AEROTROL (ISOPROTERENOL HYDROCHLORIDE)
VAPO-ISO (ISOPROTERENOL HYDROCHLORIDE)
  • ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2025-11-03
  • º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
¾Ë¸²
»ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼­ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.

°æ°í
µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù. Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡±¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.

ÀüÈ­: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
About us |  Contact us |  FAQ |  Service ¾È³» |  ±¤°í ¹× Á¦È޾ȳ» |  °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ |  Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö |  SiteMap |  °í°´Áö¿ø